Actor
AlphaOnco Swiss SA
AlphaOnco Swiss, subsidiary of Nanobacterie, is developing a cancer treatment using natural iron oxide nano-minerals, called magnetosomes, which are introduced to tumors and heated using various excitation sources (laser, ultrasound, magnetic field).
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Oncology
Main sector
Biotech
Contact
Route de l'Ile-au-Bois 1a
1870 Monthey / VS